Aarey Drugs & Pharmaceuticals: 1. The Board of Directors of the Company has considered and approved the Standalone Unaudited Financial…
Aarey Drugs & Pharmaceuticals (AAREYDRUGS) filed a disclosure titled "1. The company is valued at about ₹356 crore.
What happened
Aarey Drugs & Pharmaceuticals (AAREYDRUGS) filed a disclosure with the exchanges on 14 November 2026 at 06:49 PM titled "1. The Board of Directors of the Company has considered and approved the Standalone Unaudited Financial Results for the second quarter & half year ended on 30th September, 2026…".
Company snapshot
Aarey Drugs & Pharmaceuticals is a micro-cap company, with a market value of about ₹356 crore.
The stock last traded at ₹115.2, against a 52-week range of ₹50.31–₹116 (0.7% below the high).
Before this filing the shares had moved +11.8% over the month and +36.3% over three months. Average daily turnover over the last 20 sessions was about ₹2.18 crore.
Promoters held 42.79% at the end of Q2 FY27, up 5.08% points from the previous quarter. Foreign institutions owned 4.41% and domestic institutions 1.49%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 102 | 1.4 | 0.48 |
| Q2 FY26 | 84 | 1 | 0.72 |
| Q3 FY26 | 96 | 1.3 | 0.2 |
| Q4 FY26 | 189 | 1.6 | 0.55 |
| Q1 FY27 | 45 | 1 | 0.36 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock fell 2.5% on average the next trading day and was down 2.2% on average after five days (2 filings with price data).
Market-wide, 11,788 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 14 Aug 2026 | , the unaudited financial results for the period ended Jun 30, 2026. | −2.0% | −6.9% |
| 30 May 2026 | Audited Standalone Financial Results Of The Company For The Fourth… | −3.1% | +2.5% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 14 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.